Identifying Interventions To Delay Or Prevent Breast Cancer Recurrences After Tamoxif

[News]

An international research team led by Georgetown Lombardi Comprehensive Cancer Center has found biological differences in hormone-receptor positive breast cancer that are linked to the timing of recurrence despite endocrine therapy...

More... (http://www.medicalnewstoday.com/releases/238775.php)